← Back
$TVTX All transactions

Travere Therapeutics, Inc.

▼ SELL

$ Value

$38K

Shares

1,784

Price

$21

Filed

May 5

Insider

Name

Cline Christopher R.

Title

CHIEF FINANCIAL OFFICER

CIK

0001943192

Roles

Officer

Transaction Details

Transaction Date

2025-05-05

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

93,126

Footnotes

On September 1, 2022, the reporting person was granted performance restricted stock units (PSUs) covering 9,840 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. On May 2, 2025, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2025 that a performance criterion related to cumulative FILSPARI net revenue had been achieved. | Each PSU represents a contingent right to receive one share of the Common Stock of the Issuer. | Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested performance restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.

Filing Info

Accession No.

0001415889-25-012061

Form Type

4

Issuer CIK

0001438533

Cline Christopher R.'s History

Date Ticker Type Value
2026-04-15 TVTX $43K
2026-04-14 TVTX $370
2026-04-14 TVTX $304K
2026-04-13 TVTX A $0
2026-04-13 TVTX $2K
2025-12-01 TVTX M $325K
2025-12-01 TVTX $700K
2025-12-01 TVTX M $0
2025-09-04 TVTX $2K
2025-09-03 TVTX $8K

Other Insiders at TVTX (90d)

Insider Bought Sold Last
LYONS GARY A $329K 2026-04-14
REED ELIZABETH E
Chief Legal Officer and GC
$2.1M 2026-04-15
REED ELIZABETH E / Heerma Peter / Inrig Jula
Chief Legal Officer and GC
$303K 2026-04-14
Baynes Roy D. $1.7M 2026-04-14
ROTE WILLIAM E.
Chief Research Officer
$356K 2026-04-22
Dube Eric M
CHIEF EXECUTIVE OFFICER
$4.5M 2026-04-15
Heerma Peter
CHIEF COMMERCIAL OFFICER
2026-04-13
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
$903K 2026-04-14
Inrig Jula
CHIEF MEDICAL OFFICER
$43K 2026-04-15
Cline Christopher R.
CHIEF FINANCIAL OFFICER
$349K 2026-04-15